Studying the Hurdles of Insulin Prescription (SHIP©): Development, scoring and initial validation of a new self-administered questionnaire

Health and Quality of Life Outcomes

Volumn 5, Issue , 2007, Pages

  Martinez, Luc ^a   Consoli, Silla M ^b   Monnier, Louis ^c   Simon, Dominique ^d   Wong, Olivier ^e   Yomtov, Bernard ^f   Guéron, Béatrice ^g   Benmedjahed, Khadra ^h   Guillemin, Isabelle ^h   Arnould, Benoit ^h  

^a French Society of General Medicine   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c LAPEYRONIE HOSPITAL   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e Paris College of Family Physicians   (France)

^f HENRI MONDOR HOSPITAL   (France)

^g PFIZER INC   (United States)

^h MAPI VALUES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT; ANTIDIABETIC AGENT;

ADULT; ARTICLE; CLINICAL DECISION MAKING; CRONBACH ALPHA COEFFICIENT; DIABETES MELLITUS; FEAR; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MOTIVATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ATTITUDE; PREDICTION; PRINCIPAL COMPONENT ANALYSIS; PSYCHOLOGIC TEST; QUESTIONNAIRE; RELIABILITY; SCORING SYSTEM; STUDYING THE HURDLES OF INSULIN PRESCRIPTION; VALIDATION STUDY; AGED; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DRUG SELF ADMINISTRATION; FRANCE; INFORMATION PROCESSING; INSTRUMENTATION; MIDDLE AGED; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; STANDARD; STATISTICS; SUBCUTANEOUS DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADULT; AGED; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FOCUS GROUPS; FRANCE; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; MIDDLE AGED; PATIENT COMPLIANCE; PRINCIPAL COMPONENT ANALYSIS; PSYCHOMETRICS; QUESTIONNAIRES; SELF ADMINISTRATION;

EID: 35649022136     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-5-53     Document Type: Article

References (39)

1. Ricordeau P Weill A Vallier N Bourrel R Fender P Allemand H [Epidemiology of diabetes in metropolitan France] Diabetes Metab 2000, 26 Suppl 6.:11-24. 11011236
2. Wild S Roglic G Green A Sicree R King H Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 2004, 27:1047-1053. 10.2337/diacare.27.5.1047 15111519
3. Turner RC Millns H Neil HA Stratton IM Manley SE Matthews DR Holman RR Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23) BMJ 1998, 316:823-828. 28484 9549452
4. Hogan P Dall T Nikolov P Economic costs of diabetes in the US in 2002 Diabetes Care 2003, 26:917-932. 10.2337/diacare.26.3.917 12610059
5. Ricordeau P Weill A Vallier N Bourrel R Fender P Allemand H [The cost of diabetes in metropolitan France] Diabetes Metab 2000, 26 Suppl 6.:25-38. 11011237
6. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329:977-986. 10.1056/NEJM199309303291401 8366922
7. Klein R Hyperglycemia and microvascular and macrovascular disease in diabetes Diabetes Care 1995, 18:258-268. 10.2337/diacare.18.2.258 7729308
8. Nathan DM Singer DE Godine JE Harrington CH Perlmuter LC Retinopathy in older type II diabetics. Association with glucose control Diabetes 1986, 35:797-801. 10.2337/diabetes.35.7.797 3721064
9. Ohkubo Y Kishikawa H Araki E Miyata T Isami S Motoyoshi S Kojima Y Furuyoshi N Shichiri M Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study Diabetes Res Clin Pract 1995, 28:103-117. 10.1016/ 0168-8227(95)01064-K 7587918
10. Group UKPDS Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. BMJ 1998, 317:720-726. 28661 9732339
11. Detournay B Raccah D Cadilhac M Eschwege E Epidemiology and costs of diabetes treated with insulin in France Diabetes Metab 2005, 31:3-18. 16142041
12. Raccah D Hanaire-Broutin H Sert-Langeron C Brin S Chabrier G Fontaine PM Rodier M Vaur L Eschwege E Insulin initiation in type 2 diabetic patients admitted in hospital in France and follow-up at 1 year Diabetes Metab 2006, 32:244-250. 10.1016/S1262-3636(07)70275-6 16799401
13. Group UKPDS Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352:837-853 10.1016/S0140-6736(05)61359-1 9742976
14. Brunton SA, Davis SN, Renda SM: Overcoming psychological barriers to insulin use in type 2 diabetes. Clin Cornerstone 2006, 8 Suppl 2.:S19-S26.
15. Brunton SA Davis SN Renda SM Overcoming psychological barriers to insulin use in type 2 diabetes Clin Cornerstone 2006, 8 Suppl 2.:S19-S26 10.1016/S1098-3597(06)80012-8 16939874
16. de Sonnaville JJ Snoek FJ Colly LP Deville W Wijkel D Heine RJ Well-being and symptoms in relation to insulin therapy in type 2 diabetes Diabetes Care 1998, 21:919-924. 10.2337/diacare.21.6.919 9614608
17. Quattrin T Belanger A Bohannon NJ Schwartz SL Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: Results of a 6-month, randomized, comparative trial Diabetes Care 2004, 27:2622-2627. 10.2337/ diacare.27.11.2622 15504996
18. Freemantle N Blonde L Duhot D Hompesch M Eggertsen R Hobbs FD Martinez L Ross S Bolinder B Stridde E Availability of inhaled insulin promotes greater perceived acceptance of insulin therapy in patients with type 2 diabetes Diabetes Care 2005, 28:427-428. 10.2337/diacare.28.2.427 15677807
19. Kamoi K Miyakoshi M Maruyama R A quality-of-life assessment of intensive insulin therapy using insulin lispro switched from short-acting insulin and measured by an ITR-QOL questionnaire: A prospective comparison of multiple daily insulin injections and continuous subcutaneous insulin infusion Diabetes Res Clin Pract 2004, 64:19-25. 10.1016/ j.diabres.2003.10.005 15036823
20. Peyrot M Rubin RR Validity and reliability of an instrument for assessing health-related quality of life and treatment preferences: The Insulin Delivery System Rating Questionnaire Diabetes Care 2005, 28:53-58. 10.2337/diacare.28.1.53 15616233
21. Anderson RT Skovlund SE Marrero D Levine DW Meadows K Brod M Balkrishnan R Development and validation of the insulin treatment satisfaction questionnaire Clin Ther 2004, 26:565-578. 10.1016/S0149-2918(04)90059-8 15189754
22. Brod M Skovlund SE Wittrup-Jensen KU Measuring the impact of diabetes through patient report of treatment satisfaction, productivity and symptom experience Qual Life Res 2006, 15:481-491. 10.1007/ s11136-005-1624-6 16547787
23. Bradley C Diabetes Treatment Satisfaction Questionnaire (DTSQ) Handbook of Psychology and Diabetes Chur, Harwood Academic Publishers Bradley C 1994:111-132.
24. Cappelleri JC Gerber RA Kourides IA Gelfand RA Development and factor analysis of a questionnaire to measure patient satisfaction with injected and inhaled insulin for type 1 diabetes Diabetes Care 2000, 23:1799-1803. 10.2337/diacare.23.12.1799 11128356
25. Brod M Cobden D Lammert M Bushnell D Raskin P Examining correlates of treatment satisfaction for injectable insulin in type 2 diabetes: lessons learned from a clinical trial comparing biphasic and basal analogues Health Qual Life Outcomes 2007, 5:8. 8 10.1186/1477-7525-5-8
26. Brod M Christensen T Bushnell D Maximizing the value of validation findings to better understand treatment satisfaction issues for diabetes Qual Life Res 2007, 16:1053-1063. 10.1007/s11136-007-9209-1 17516149
27. Kitzinger J Qualitative research. Introducing focus groups BMJ 1995, 311:299-302. 7633241
28. Streiner DL Norman GR Health measurement scales. A practical guide to their development and use Oxford, Oxford University Press 3rd 2003.
29. Mollema ED Snoek FJ Pouwer F Heine RJ van der Ploeg HM Diabetes Fear of Injecting and Self-Testing Questionnaire: A psychometric evaluation Diabetes Care 2000, 23:765-769. 10.2337/diacare.23.6.765 10840993
30. Campbell DT Fiske DW Convergent and discriminant validation by the multitrait-multimethod matrix Psychol Bull 1959, 56:81-105. 10.1037/ h0046016 13634291
31. Hays RD Hayashi T Beyond internal consistency reliability: Rationale and user's guide for Multitrait analysis program on the microcomputer Behav Res Methods Instrum Comput 1990, 22:167-175.
32. Cronbach LJ Coefficient Alpha and the Internal Structure of Tests Psychometrika 1951, 16:297-334. 10.1007/BF02310555
33. Nunnally JC Bernstein IH Psychometric theory New York, McGraw-Hill Inc 3rd 1994
34. Chassany O Sagnier P Marquis P Fullerton S Aaronson N Patient-reported outcomes: The example of health-related quality of life - A European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process Drug Inf J 2002, 36:209-238.
35. Agresti A Categorical data analysis Hoboken, NJ Wiley JSI 2nd 2002:228-230.
36. Ajzen I From intentions to actions: A theory of planned behavior Action control: From cognition to behavior New York, New York J.Kuhl Springer Verlag 1985:11-39.
37. Ajzen IFM Understanding Attitudes and Predicting Social Behavior Prentice-Hall, Englewood Cliffs, NJ 1980.
38. Francis JJ Eccles MP Johnston M Walker A Grimshaw J Foy R Kaner EF Smith L Bonetti D Constructing questionnaires based on the Theory of Planned Behaviour: A manual for health services researchers University of Newcastle Upon Tyne University of Newcastle Upon Tyne: Centre for Health Services Research 2004
39. Arnould B Patient-Reported Outcomes in clinical practice. From measurement instruments to decision tools: Much more than a simple change in format PRO Newsletter 2006, 36:21-24.